Cargando…
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431559/ https://www.ncbi.nlm.nih.gov/pubmed/37601463 http://dx.doi.org/10.1097/AS9.0000000000000290 |
Ejemplares similares
-
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
por: Kjaer, Josefine, et al.
Publicado: (2022) -
Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems: Erratum
Publicado: (2016) -
Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis
por: Yang, Zhen, et al.
Publicado: (2022) -
TNM Staging of Pancreatic Neuroendocrine Tumors: An Observational Analysis and Comparison by Both AJCC and ENETS Systems From 1 Single Institution: Erratum
Publicado: (2016) -
Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis
por: Sun, Jianhui, et al.
Publicado: (2022)